Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for treating PTEN deficient epithelial cancers using a combination of anti-PI3KBETA and anti-immune checkpoint agents

Methods for treating PTEN deficient epithelial cancers using a combination of anti-PI3KBETA and anti-immune checkpoint agents

US Patent 10960008 · Granted Mar 30, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Cancer vaccine compositions and methods for using same to prevent and/or treat c2025
Method of assessing the efficacy of a test agent for modulating programmed death2025
Surgical stapling instrument having a two-position lockout mechanism2025
Mesothelin chimeric antigen receptor (CAR) and antibody against PD-L1 inhibitor 2025
Methods for upregulating immune responses using combinations of anti-RGMb and an2024
KIR3DL3 as an HHLA2 receptor, anti-HHLA2 antibodies, and uses thereof2024
Antibody molecules to PD-1 and uses thereof2023
Surgical stapling instrument having a two-position lockout mechanism2023
Compositions and methods for identification, assessment, prevention, and treatme2023
Anti-phosphotyrosinylated programmed death 1 (PD-1) monoclonal antibodies, metho2022
Agents that modulate RGMb-neogenin-BMP signaling and methods of use thereof2022
Mesothelin chimeric antigen receptor (CAR) and antibody against PD-L1 inhibitor 2022